Cargando…
Metoclopramide as a prokinetic agent for diabetic gastroparesis: revisiting the risk of Parkinsonism
BACKGROUND: Metoclopramide is used to relieve gastrointestinal symptoms, however, it could cause adverse reactions of motor disorders. The aim of this study was to investigate whether metoclopramide treatment has a duration–response or dose–response effect and to estimate the risk of developing Park...
Autores principales: | Lai, Chien-Hsu, Yeh, Yi-Chun, Chen, Yen-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587390/ https://www.ncbi.nlm.nih.gov/pubmed/31258887 http://dx.doi.org/10.1177/2042098619854007 |
Ejemplares similares
-
Evaluation of prokinetic agents used in the treatment of gastroparesis
por: Roe, Neil A, et al.
Publicado: (2017) -
Efficacy of prokinetic agents in diabetic gastroparesis comparing symptomatology and scintigraphy – An open-label trial
por: Kant, Ravi, et al.
Publicado: (2023) -
Efficacy and Safety of Mecobalamin Combined with Prokinetic Agents in the Treatment of Diabetic Gastroparesis: A Meta-Analysis
por: Yao, Jia, et al.
Publicado: (2021) -
Should we stop prescribing metoclopramide as a prokinetic drug in critically ill patients?
por: van der Meer, Y Gert, et al.
Publicado: (2014) -
Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis
por: Shah, Shamik, et al.
Publicado: (2013)